Tweet
Effect of Over-Represented Transcripts on DEG Analysis
We have a fairly simple set of RNA-seq data that we are using to perform a DEG analysis, breifly, a wild-type strain and a single gene knock out (in yeast). One issue we have is that the yeast is auxotrophic, meaning our wild-type line does not produce transcripts of the gene TRP1, while our knock-out selection marker is TRP1, meaning there is a huge fold change of that gene in the DEG analysis. We are also noticing that there seems to an "over representation" of certain genes, representing a large portion of the sequenced reads. This seems to shrink the fold changes of genes we know are differentially expressed, verfied by RT-qPCR. Is there a way to account for this "diltution effect" when using a DEG program like deseq2?
-
-
Dear evanso08, to deal with TRP1, if it's only expressed in one of your strains and you've verified that you find only transcripts of it in the mutant strain, just remove it from the analysis as huge fold changes can sometimes distort the fitted dispersion of other genes.
As far as over representation of other genes, if this phenomenon is comparable between your two compared experimental conditions, you may also just remove these genes from the analysis and perform a DESeq2 DEG identification on the remaining genes. That's common when studying cell types which produce large amount of specific RNA, like immunoglobulin light and heavy chains for B lymphocytes for example.
Finally, it could be interesting to investigate why you get such an over-representation and what is the function of the over-represented genes.
Good luck!
-
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM
Comment